Asthma is the most common chronic disease in infants and children affecting just over one in ten of the paediatric population in the UK. Control and management of asthma symptoms is key to reducing the long term consequences of the condition and preventing acute asthma attacks, which can cause significant distress and often results in hospital admission.
In this seminar, two experts will showcase research into new treatments in paediatric asthma and new approaches to population health management to reduce the individual and population impacts of this chronic condition.

Speakers

Professor Sejal Saglani

Professor Saglani leads the Paediatric Severe Asthma Group in the National Heart and Lung Institute at Imperial College London and is an Honorary Consultant in Paediatric Respiratory Medicine, Royal Brompton Hospital. Her research is focussed on understanding the biological factors that cause childhood asthma and wheezing and developing effective treatments.

Dr Bob Klaber

Dr Klaber is a Consultant General Paediatrician at Imperial College Healthcare NHS Trust with an active interest in improving population health and well-being and reducing health inequalities through development of new models of care. He is also Director of Strategy, Research and Innovation at the Trust.